Myeloid Leukemia [clinicaltrials_resource:ead5d113845559043355fa0521ef29d5]
Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults [clinicaltrials:NCT00001637]HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies [clinicaltrials:NCT00001748]clinicaltrials:NCT00111345Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML) [clinicaltrials:NCT00114764]Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia [clinicaltrials:NCT00126893]Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®) [clinicaltrials:NCT00422890]Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia [clinicaltrials:NCT00497991]A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups [clinicaltrials:NCT00521664]Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia [clinicaltrials:NCT00543972]clinicaltrials:NCT00887926Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor [clinicaltrials:NCT00967343]Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia [clinicaltrials:NCT01066286]Genome-wide Pharmacogenetic Candidate Gene Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Myeloid Leukemia With Normal Karyotype [clinicaltrials:NCT01066338]Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia [clinicaltrials:NCT01380756]clinicaltrials:NCT01643603Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT [clinicaltrials:NCT01779882]Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine [clinicaltrials:NCT02489929]
condition [clinicaltrials_vocabulary:condition]
Myeloid Leukemia [clinicaltrials_resource:ead5d113845559043355fa0521ef29d5]
Bio2RDF identifier
ead5d113845559043355fa0521ef29d5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ead5d113845559043355fa0521ef29d5
identifier
clinicaltrials_resource:ead5d113845559043355fa0521ef29d5
title
Myeloid Leukemia
@en
label
Myeloid Leukemia [clinicaltrials_resource:ead5d113845559043355fa0521ef29d5]
@en